These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 591461)

  • 1. Metabolites of gentamicin-producing Micromonospora species I. Isolation and identification of metabolites.
    Bérdy J; Pauncz JK; Vajna ZM; Horváth G; Gyimesi J; Koczka I
    J Antibiot (Tokyo); 1977 Nov; 30(11):945-54. PubMed ID: 591461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of gentamicin antibiotics produced by Micromonospora purpurea.
    Abou-Zeid AA; Eissa AI; Salem HM
    Zentralbl Bakteriol Naturwiss; 1978; 133(4):362-8. PubMed ID: 726708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. I. Conversion of aminocyclitols to new aminoglycoside antibiotics.
    Rosi D; Goss WA; Daum SJ
    J Antibiot (Tokyo); 1977 Jan; 30(1):88-97. PubMed ID: 320170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of gentamicin C compounds from culture filtrates of Micromonospora purpurea.
    Jork H; Kunz FR
    J Chromatogr; 1988 Oct; 450(1):115-9. PubMed ID: 3220920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicins.
    Abou-Zeid AA; Shehata YM
    Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1977; 132(2):97-108. PubMed ID: 327729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gentamicin antibiotics. 6. Gentamicin C2b, an aminoglycoside antibiotic produced by Micromonospora purpurea mutant JI-33.
    Daniels PJ; Luce C; Nagabhushan TL
    J Antibiot (Tokyo); 1975 Jan; 28(1):35-41. PubMed ID: 1092638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of gentamicin C-complex into five components by Craig distribution.
    Byrne KM; Kershner AS; Maehr H; Marquez JA; Schaffner CP
    J Chromatogr; 1977 Jan; 131():191-203. PubMed ID: 856852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a gentamicin C1a-overproducing strain of Micromonospora purpurea by inactivation of the gacD gene.
    Li D; Li H; Ni X; Zhang H; Xia H
    Microbiol Res; 2013 Jun; 168(5):263-7. PubMed ID: 23305768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. II. Conversion of non-amino containing cyclitols to aminoglycoside antibiotics.
    Daum SJ; Rosi D; Goss WA
    J Antibiot (Tokyo); 1977 Jan; 30(1):98-105. PubMed ID: 838635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of 3″-demethyl-gentamicin C components by genN disruption strain of Micromonospora echinospora and test their antimicrobial activities in vitro.
    Ni X; Zong T; Zhang H; Gu Y; Huang M; Tian W; Xia H
    Microbiol Res; 2016 Apr; 185():36-44. PubMed ID: 26946376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sagamicin and the related aminoglycosides: fermentation and biosynthesis. I. Biosynthetic studies with the blocked mutants of Micromonospora sagamiensis.
    Kase H; Odakura Y; Nakayama K
    J Antibiot (Tokyo); 1982 Jan; 35(1):1-9. PubMed ID: 7082452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving gentamicin B and gentamicin C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis.
    Wu Z; Gao W; Zhou S; Wen Z; Ni X; Xia H
    Microbiol Res; 2017 Oct; 203():40-46. PubMed ID: 28754206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of antibiotic SU-2 complex by a 2-deoxystreptamine idiotroph of Micromonospora sagamiensis.
    Kase H; Kitamura S; Nakayama K
    J Antibiot (Tokyo); 1982 Apr; 35(4):385-90. PubMed ID: 7096193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry.
    Grahek R; Zupancic-Kralj L
    J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sisomicin: a review of eight years' experience.
    Sanders WE; Sanders CC
    Rev Infect Dis; 1980; 2(2):182-95. PubMed ID: 6994206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic engineering combined with random mutagenesis to enhance G418 production in Micromonospora echinospora.
    Ni X; Sun Z; Zhang H; He H; Ji Z; Xia H
    J Ind Microbiol Biotechnol; 2014 Sep; 41(9):1383-90. PubMed ID: 25031027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micromonospora-produced sisomicin components.
    Lee BK; Condon RG; Wagman GH; Weinstein MJ; Katz E
    J Antibiot (Tokyo); 1976 Jul; 29(7):677-84. PubMed ID: 956052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromonospora-produced gentamicin components.
    Lee BK; Condon RG; Wagman GH; Katz E
    Antimicrob Agents Chemother; 1976 Jan; 9(1):151-9. PubMed ID: 1259389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sagamicin and the related aminoglycosides: fermentation and biosynthesis. III. Isolation and characterization of Micromonospora sagamiensis mutants blocked in gentamicin C1 pathway.
    Odakura Y; Kase H; Nakayama K
    J Antibiot (Tokyo); 1983 Feb; 36(2):125-30. PubMed ID: 6833127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of aminoglycoside antibiotic 66-40G produced by Micromonospora inyoensis.
    Kugelman M; Jaret RS; Mittelman S; Gau W
    J Antibiot (Tokyo); 1978 Jul; 31(7):643-5. PubMed ID: 689999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.